EBSEmergent Biosolutions, Inc.

CSNew York Stock Exchange (XNYS)·USD

Identity

Security key: 14570
Ticker: EBS
Type: CS — Common Stock
Exchange: New York Stock Exchange(XNYS)
Venue group: NYSE
Operating MIC: XNYS
Market: stocks
Locale: us
Currency: USD
Listed: 2006-11-15
Round lot: 100
Active: Yes
Last seen in a load: 2026-08-14 20:49
Vendor updated: 2026-08-13 06:09
Ticker root / suffix: EBS

Detail

Enriched 2026-08-14 20:47

Market cap: $233,293,678.8
Shares outstanding (class): 51,273,336
Shares outstanding (weighted): 51,273,336
SIC: 2834 PHARMACEUTICAL PREPARATIONS
Employees: 900
Location: GAITHERSBURG, MD
Homepage: https://www.emergentbiosolutions.com
Description: Emergent BioSolutions Inc offers public health products to the government and healthcare providers. Company operates in three segments namely Commercial Product, MCM Products, and Services segment. The Commercial Product Segment consisting of Nasal Spray; the MCM Products Segment consisting of Anthrax-MCM products, Smallpox-MCM products and Other Products and the Services Segment consisting of Bioservices portfolio. Geographically, the company operates in United States, Canada, and Others. It derives maximum revenue from United states. The company's products include: NARCAN Nasal Spray, KLOXXADO Nasal Spray, ACAM2000, ANTHRASIL, BAT, BioThrax, CNJ-016, raxibacumab injection, Ebanga, and others.

Market cap and share counts drift.

Funds holding this security

95 funds · 96 positions · $71.64M reported value, as of 2026-03-31

All holders →

Fund	Ticker	Position value	% of fund	Balance	Match
VANGUARD TOTAL STOCK MARKET INDEX FUND VANGUARD INDEX FUNDS	VTI	$13.35M	0.00%	1,608,616 NS	FIGI
State Street(R) SPDR(R) S&P(R) Biotech ETF SPDR SERIES TRUST	XBI	$13.06M	0.18%	1,572,925 NS	FIGI
iShares Russell 2000 ETF iShares Trust	IWM	$10.64M	0.01%	1,282,039 NS	FIGI
VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS	VXF	$4.92M	0.01%	593,314 NS	FIGI
VANGUARD STRATEGIC EQUITY FUND VANGUARD HORIZON FUNDS	—	$3.86M	0.04%	465,318 NS	FIGI
iShares Russell 2000 Value ETF iShares Trust	IWN	$3.68M	0.03%	443,552 NS	FIGI
iShares Biotechnology ETF iShares Trust	IBB	$3.12M	0.04%	376,503 NS	FIGI
PIMCO RAE US Small Fund PIMCO Equity Series	—	$2.74M	0.09%	330,315 NS	FIGI
Small Cap Value Fund Northern Funds	—	$1.21M	0.20%	146,094 NS	FIGI
iShares Micro-Cap ETF iShares Trust	IWC	$1.09M	0.09%	131,354 NS	FIGI
Fidelity Enhanced Small Cap ETF Fidelity Covington Trust	FESM	$997.2K	0.02%	120,148 NS	FIGI
State Street Institutional Small-Cap Equity Fund STATE STREET INSTITUTIONAL FUNDS	—	$953.2K	0.20%	114,839 NS	FIGI
Ancora/Thelen Small-Mid Cap Fund ANCORA TRUST	—	$871.7K	0.41%	105,025 NS	FIGI
Master Small Cap Index Series Quantitative Master Series LLC	—	$709.3K	0.01%	85,455 NS	FIGI
FULLERTHALER BEHAVIORAL MICRO-CAP EQUITY FUND Capitol Series Trust	—	$677.7K	3.07%	81,655 NS	FIGI

How positions resolve to the securities master. FIGI_COMPOSITE is exact identifier equality — both sides got the FIGI from Bloomberg. TICKER is a narrow fallback used only where the master row carries no FIGI at all (2,389 rows do not, disproportionately Irish-domiciled US listings like LIN and ACN). Roughly 22% of all positions resolve to the master.

Funds holding this security

Identifiers

master.security_identifier

TICKEREBS
FIGI_COMPOSITEBBG000GW06J7
FIGI_SHARE_CLASSBBG001SP1G40
CIK0001367644
ISINUS29089Q1058
Resolved through OpenFIGI from a holdings ISIN, not supplied by the securities vendor.

Identifiers

Classification

classification.v_security_classification

Asset class: Equity
Sector: Health Care
Industry: Pharmaceuticals
Source: LLMunreviewed
Self-reported confidence: 0.95
Model: deepseek
Rationale: Emergent Biosolutions is a pharmaceutical company, as indicated by its SIC code 2834.

Classifications are unreviewed model output. All 5,771 assignments carry source = LLM and is_reviewed = false. Confidence is the model’s own estimate and is not calibrated — it clustered at 0.90–0.98 across the whole first pass, including rows that later proved wrong. Use it to order a review queue, not as a probability. Two share classes of one issuer can disagree.

Classification

Fund data

Not linked to a fund series.

Either this is not a fund, or it is one the SEC share-class snapshot cannot reach — commodity trusts and notes have no series ID at all.